In the next step, to evaluate whether RAD21 gene promoter methylation is associated with specific cytogenetic abnormalities, the cytogenetic profile and the clinicopathological characteristics of the AML patients were correlated with the methylation data. This evidence concerns the gene RAD21 and acute myeloid leukemia.